Unlearn

Unlearn AI is a California-based company dedicated to revolutionizing clinical drug development through the power of artificial intelligence. Our cutting-edge technology focuses on generative machine learning methods, allowing us to predict individual health outcomes and simulate potential futures using patient digital twins.

With our digital twins, we can forecast how a patient's health may change over time, compare potential health outcomes, and estimate the relative effects of different treatments. By partnering with innovators in the pharma and biotech industry, we accelerate the clinical drug development process and facilitate faster enrollment in AI-powered clinical trials.

At Unlearn AI, our ultimate goal is to build the future of medicine. We are actively seeking innovative individuals who share our passion for advancing AI technology in healthcare. Join us as we work towards eliminating the trial and error process and improving treatment outcomes for patients.

Our technology finds its main application in AI-powered clinical trials. By utilizing our digital twins, we can simulate 'what if?' scenarios to compare potential health outcomes of different treatments. This allows us to speed up the clinical trial process and prioritize patient well-being at every step of the way.

Unlearn AI's mission is to advance AI technology to eventually eliminate the trial and error process in medicine. By leveraging AI and simulation, we aim to enable predictive analysis and inform better clinical decision-making, ultimately improving the lives of patients and transforming the healthcare industry.